IP And Trademarks 11 November 2026
TempraMed Secures U.S. Patent for VIVI Cap Smart
TempraMed has received a United States patent for its Pen Agnostic VIVI Cap Smart technology, a key component of its VIVI Cap Smart(TM) platform. The grant bolsters the company's global intellectual property portfolio and underscores its innovation in smart pen solutions, enhancing market positioning and potential licensing opportunities.
- Patent granted: TempraMed secured a U.S. patent for its Pen Agnostic VIVI Cap Smart™ technology, strengthening its IP position.
- Strategic impact: The approval enhances the company’s global portfolio, supports market expansion, and opens licensing avenues.
Read more at TempraMed U.S. Patent Announcement.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.